Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:753

Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2006;114:753.)
© 2006 American Heart Association, Inc.

Issue Highlights


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    RISK OF THROMBOEMBOLIC EVENTS AFTER PERCUTANEOUS LEFT ATRIAL RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION, by Oral et al.
 
In patients with atrial fibrillation (AF), thromboembolism and the need for anticoagulation influence the risks and benefits of catheter ablation for maintaining sinus rhythm. Ablation has a risk of thromboembolism. After a successful procedure, withdrawal of anticoagulation would be attractive to many patients, but there are limited data on the safety of this approach. Oral and colleagues examined these issues in a 755 consecutive patients with AF. They observed a 1.1% risk of thromboembolism during the first few weeks after catheter ablation. After >3 months, warfarin was discontinued in selected low-risk patients. This low-risk group did not experience thromboembolic events during follow-up. These findings provide an estimate of early thromboembolism risk and support withdrawal of anticoagulation in selected low-risk patients who are in sinus rhythm late after AF ablation. Further data are needed addressing warfarin withdrawal in higher-risk groups who undergo a successful ablation procedure. See p 759.


*    ADVERSE IMPACT OF BLEEDING ON PROGNOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES, by Eikelboom et al.
 
Although great progress has been made in the treatment of patients with acute coronary syndromes, many of the commonly used pharmacological and interventional treatments are associated with increased risk of bleeding. In this issue of Circulation, Eikelboom and colleagues study 34 146 patients from the Organization to Assess Ischemic Syndromes (OASIS) and Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) studies to determine if bleeding was associated with adverse clinical outcome. They report that in patients with acute coronary syndromes without persistent ST-segment elevation, there was a strong association between bleeding and death. Although bleeding is typically considered a . . . [Full Text of this Article]


Related Articles:

Heparin-Induced Thrombocytopenia
Steven A. Baroletti and Samuel Z. Goldhaber
Circulation 2006 114: e355-e356. [Extract] [Full Text]

Contrast-Enhanced Magnetic Resonance Imaging of a Patient With Chloroquine-Induced Cardiomyopathy Confirmed by Endomyocardial Biopsy
Thorsten Reffelmann, Amjad Naami, Elmar Spuentrup, and Harald Peter Kühl
Circulation 2006 114: e357-e358. [Extract] [Full Text]

Iatrogenic Internal Mammary Artery-to-Great Cardiac Vein Anastomosis
Ulises Rojel Martínez, Rodrigo Zataraín Rivero, Carlos Morales Salgado, Javier Moreno Buenrostro, and Jose Antonio Velasco Barcena
Circulation 2006 114: e359. [Extract] [Full Text]

Silent Double Aortic Arch Found in an Elderly Man
Hiroshi Ikenouchi, Fumiko Tabei, Nobuhiko Itoh, and Akira Nozaki
Circulation 2006 114: e360-e361. [Extract] [Full Text]

Letter by Tsai et al Regarding Article, "Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents"
Thomas T. Tsai, Brahmajee K. Nallamothu, and Eric R. Bates
Circulation 2006 114: e362. [Extract] [Full Text]

Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions: Clinical and Angiographic Results of the ENDEAVOR II Trial
Jean Fajadet, William Wijns, Gert-Jan Laarman, Karl-Heinz Kuck, John Ormiston, Thomas Münzel, Jeffrey J. Popma, Peter J. Fitzgerald, Raoul Bonan, Richard E. Kuntz for the ENDEAVOR II Investigators
Circulation 2006 114: 798-806. [Abstract] [Full Text]

Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
John W. Eikelboom, Shamir R. Mehta, Sonia S. Anand, Changchun Xie, Keith A.A. Fox, and Salim Yusuf
Circulation 2006 114: 774-782. [Abstract] [Full Text]

Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
Hakan Oral, Aman Chugh, Mehmet Özaydin, Eric Good, Jackie Fortino, Sundar Sankaran, Scott Reich, Petar Igic, Darryl Elmouchi, David Tschopp, Alan Wimmer, Sujoya Dey, Thomas Crawford, Frank Pelosi, Jr, Krit Jongnarangsin, Frank Bogun, and Fred Morady
Circulation 2006 114: 759-765. [Abstract] [Full Text]